Breast Cancer: Setting Priorities for Effectiveness Research (1990)

Andersson, I., Aspergren, K., Janzon, L., et al. Mammographic Screening and Mortality from Breast Cancer: The Malmö Mammographic Screening Trial. British Medical Journal 297:943–948, 1988.

Bader, J., Lippman, M., Swain, S., et al. Preliminary Report of the NCI Early Breast Cancer Study: A Prospective Randomized Comparison of Lumpectomy and Radiation to Mastectomy for Stage I and II Breast Cancer. International Journal of Radiation Oncology, Biology, and Physics 13(Supplement 1):160 (Abstract 138), 1987.

Carter, C.L., Corle, D.K., Micozzi, M.S., et al. Prospective Study of the Development of Breast Cancer in 16,692 Women With Benign Breast Disease. American Journal of Epidemiology 128:467–477, 1988.

Chu, K.C., Smart, C.R., and Tarone, R.E. Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trials. Journal of the National Cancer Institute 80:1125–1132, 1988.

DeVita, V.T. Breast Cancer Therapy: Exercising All Our Options. New England Journal of Medicine 320:327–329, 1989.

Early Breast Cancer Trialists’ Collaborative Group. Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer. New England Journal of Medicine 319:1681–1692, 1988.

Eddy, D.M., Hasselblad, V., McGivney, W., et al. The Value of Mammography Screening in Women Under Age 50 Years. Journal of the American Medical Association 259:1512–1519, 1988.

Feig, S.A., and McLelland, R. Breast Carcinoma: Current Diagnosis and Treatment. New York: American College of Radiology, Masson Publishing USA, Inc., 1983.

Fisher, B., Bauer, M., Margolese, R., et al. Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy With or Without Radiation in the Treatment of Breast Cancer. New England Journal of Medicine 312:665–673, 1985.

Fisher, B., Redmond, C., Fisher, E.R., et al. Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy With or Without Radiation. New England Journal of Medicine 312:674–681, 1985.

Fisher, B., Redmond C., Dimitrov, N.V., et al. A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients With Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors. New England Journal of Medicine 320:473–478, 1989.

Fisher, B., Costantino, J., Redmond, C., et al. A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients With Node-Negative Breast Cancer Who Have Estrogen-Receptor-Positive Tumors. New England Journal of Medicine 320:479–484, 1989.

Fisher, B., Redmond, C., Poisson, R., et al. Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy With or Without Irradiation in the Treatment of Breast Cancer. New England Journal of Medicine 320:822–828, 1989.

Greenfield, S., Blanco, D.M., Elashoff, R.M., et al. Patterns of Care Related to Age of Breast Cancer Patients. Journal of the American Medical Association 257:2766–2770, 1987.

Kantorowitz, D.A., Poulter, C.A., Sischy, B., et al. Treatment of Breast Cancer among Elderly Women With Segmental Mastectomy or Segmental Mastectomy Plus Postoperative Radiotherapy. International Journal of Radiation Oncology, Biology, and Physics 15:263–270, 1988.

Harris, J.R., Hellman, S., Henderson, I.C., et al. (eds). Breast Diseases. Philadelphia, Pa.: J.B. Lippincott Company, 1987.

Kopans, D.B. Breast Imaging. Philadelphia, Pa.: J.B. Lippincott Company, 1989.

The Ludwig Breast Cancer Study Group. Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast Cancer. New England Journal of Medicine 320:491–496, 1989.

Mann, B.A., Samet, J.M., Hung, W.C., et al. Changing Treatment of Breast Cancer in New Mexico From 1969 Through 1985. Journal of the American Medical Association 259:3413–3417, 1988.

Mansour, E.G., Gray, R., Shatila, A.H., et al. Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer. An Intergroups Study. New England Journal of Medicine 320:485–490, 1989.

McGuire, W.L. Adjuvant Therapy of Node-Negative Breast Cancer. New England Journal of Medicine 320:525–527, 1989.

Morris, J., and Ingham, R. Choice of Surgery for Early Breast Cancer: Psychosocial Considerations. Social Science and Medicine 27(11): 1257–1262, 1988.

Relman, A.S. Adjuvant Treatment of Early Breast Cancer. New England Journal of Medicine 320:525, 1989.

Sarrazin, D., Le, M.G., Arriagada, R., et al. Ten-Year Results of a Randomized Trial Comparing a Conservative Treatment of Mastectomy in Early Breast Cancer. Radiotherapy and Oncology 14:177–184, 1989.

Veronesi, U., Banfi, A., DelVecchio, M., et al. Comparison of Halsted Mastectomy with Quadrantectomy, Axillary Dissection and Radiotherapy in Early Breast Cancer: Long-Term Results. European Journal of Cancer and Clinical Oncology 22:1085–1089, 1986.

Yancik, R., Ries, L.G., and Yates, J.W. Breast Cancer in Aging Women. A Population-based Study of Contrasts in Stage, Surgery and Survival. Cancer 63:976–981, 1989.

Zucali, R., Luini, A., DelVecchio, M., et al. Contralateral Breast Cancer After Limited Surgery Plus Radiotherapy of Early Mammary Tumors. European Journal of Surgical Oncology 13:413–417, 1989.

American Medical Association. Report of the Council on Scientific Affairs. Report F (A-88). Mammography Screening in Asymptomatic Women 40 Years and Older (Resolution 93, I-87). Chicago, Ill.: American Medical Association, October 1988.

General Accounting Office. Breast Cancer. Patients’ Survival. PEMD-89–9. Washington D.C.: U.S. General Accounting Office, February 1989.

Office of Technology Assessment. Breast Cancer Screening for Medicare Beneficiaries: Effectiveness, Cost to Medicare and Medical Resources Required. U.S. Congress, Office of Technology Assessment, Health Program. November 1987.

Katz, S. (ed.). The Portugal Conference: Measuring Quality of Life and Functional Status in Clinical and Epidemiologic Research. Proceedings. Journal of Chronic Diseases 40(6):459–650, 1987.

Lohr, K.N., guest ed. Advances in Health Status Assessment. Proceedings of a Conference. Medical Care 27(March Supplement):S1–S294, 1989.

Lohr, K.N., and Ware, J.E., Jr., eds. Advances in Health Assessment Conference Proceedings. Journal of Chronic Diseases 40(Supplement): 1S–193S, 1987.

McDowell, I., and Newell, C. Measuring Health. A Guide to Rating Scales and Questionnaires. New York: Oxford University Press, 1987.

Mor, V. Cancer Patients’ Quality of Life over the Disease Course: Lessons From the Real World. Journal of Chronic Diseases 40(6):535–544, 1987.

Mosteller, F., and Falotico-Taylor, J., eds. Quality of Life and Technology Assessment. Monograph of the Council on Health Care Technology. Washington, D.C.: National Academy Press, 1989.

O’Young, J., and McPeek, B. Quality of life Variables in Surgical Trials. Journal of Chronic Diseases 40(6):513–522, 1987.

Health Care Financing Administration. An excerpt entitled “Medicare statistical system” from Health Care Financing Program Statistics. Medicare and Medicaid Data Book, 1986. HCFA Pub. No. 03247. Baltimore, Md.: U.S. Department of Health and Human Services, Health Care Financing Administration, September 1987.

Health Care Financing Administration. Excerpts from the Medicare Statistical Files Manual. Baltimore, Md.: Health Care Financing Administration, Bureau of Data Management and Strategy, HCFA Pub. No. 03272, July 1988.

Health Care Financing Administration. An internal document entitled “Project to Redesign Information Systems Management (PRISM).” Baltimore, Md.: U.S. Department of Health and Human Services, Health Care Financing Administration, mimeo, no date.

National Cancer Institute. Working Guidelines for Early Cancer Detection—Rational and Supporting Evidence to Decrease Mortality. Bethesda, Md.: National Cancer Institute, Division of Cancer Prevention and Control, Early Detection Branch, December, 1987

Tables and narrative describing current and recent clinical trials activity sponsored by the National Cancer Institute. Submitted by Dr. Andrew Dorr of the Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment via letter to Kim Heithoff, IOM staff member, dated February 6, 1989.